Comparison

CDKI-73 European Partner

Item no. TMO-T14919-2mg
Manufacturer TargetMol
CASRN 1421693-22-2
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles CNc1nc(C)c(s1)-c1nc(Nc2cccc(c2)S(N)(=O)=O)ncc1F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1421693-22-2
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis|||CDK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
394.45
Description
CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin.
Pathways
Cell Cycle/Checkpoint|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close